Phase 1 drug-drug interaction study to assess the effect of CYP3A4 inhibition and pan-CYP induction on the pharmacokinetics and safety of fosmanogepix in healthy participants.

Michael R Hodges, Sjoerd Van Marle + Show 5 more

Open Access

https://doi.org/10.1128/aac.01650-23

Copy DOI

Journal: Antimicrobial agents and chemotherapy	Publication Date: May 17, 2024
License type: CC BY 4.0

Abstract

This study is registered with ClinicalTrials.gov as NCT04166669 and with EudraCT as number 2019-003586-17.

Full Text

Published version (

Free)

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Paper Title

Journal

Date

Author